1996
DOI: 10.1093/infdis/173.3.699
|View full text |Cite
|
Sign up to set email alerts
|

Differential Expression of Chemokines in Patients with Localized and Diffuse Cutaneous American Leishmaniasis

Abstract: The abundance of macrophages in localized cutaneous leishmaniasis (LCL) and diffuse cutaneous leishmaniasis (DCL) lesions and differences in the composition of T cell subsets indicate involvement of cell-specific chemotaxis processes. The expression of macrophage chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1 alpha and -1 beta, RANTES (regulated on activation, normal T cell expressed and secreted), I-309, and interleukin-8 were investigated in lesions of patients with LCL or DCL. In L… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
112
1

Year Published

1998
1998
2013
2013

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 108 publications
(121 citation statements)
references
References 36 publications
8
112
1
Order By: Relevance
“…For example, patients suffering from cutaneous leishmaniasis show a significant increase in levels of MCP-1 and MIP-1a mRNA in their lesions [34]. Similarly, infection of mouse and human macrophages with L. major promastigotes induces expression of several chemokines such as MCP-1, IL-8, and MCAF [35][36][37].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, patients suffering from cutaneous leishmaniasis show a significant increase in levels of MCP-1 and MIP-1a mRNA in their lesions [34]. Similarly, infection of mouse and human macrophages with L. major promastigotes induces expression of several chemokines such as MCP-1, IL-8, and MCAF [35][36][37].…”
Section: Resultsmentioning
confidence: 99%
“…These findings demonstrate that CXCR3 plays a crucial role in the host defense against L. major by regulating the immune response required for controlling parasite growth at the site of infection. Several studies have implicated a role for chemokines in regulation of the immune response during Leishmania infection [34][35][36][37][38][39][40][41]. For example, patients suffering from cutaneous leishmaniasis show a significant increase in levels of MCP-1 and MIP-1a mRNA in their lesions [34].…”
mentioning
confidence: 99%
“…This complement activation, among an array of other factors, creates a C5a gradient along which macrophages are chemotactically attracted [36]. Furthermore, differential expressions of chemokines such as macrophage chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1a and -1b, RANTES (Regulated on Activation, Normal T cell Expressed and presumably Secreted), I-309, interleukin (IL)-8, and adhesion molecules, have been reported in American cutaneous leishmaniasis [37,38]. The chemotaxis could also occur through continuous synthesis by living promastigotes of a cell membrane-associated factor(s), because promastigote culture supernatant failed to modulate the macrophage migration, indicating that the factor(s) responsible for chemotaxis is not released into the surrounding medium.…”
Section: Discussionmentioning
confidence: 99%
“…For over a decade, Leishmania has been known to induce or inhibit the expression of chemokines to control recruitment of immune cells. In human cutaneous leishmaniasis, the diffuse form of the disease has been associated with lower levels of the macrophage chemotactic factor CCL2 (MCP-1), which is higher in the localized form of the disease (Ritter et al, 1996). Since CCL2 also induces antiparasitic activity in macrophages (Mannheimer, Hariprashad, Stoeckle, & Murray, 1996), inhibition of this chemokine by Leishmania could potentially facilitate its survival within the host.…”
Section: Mechanisms Of Immune Evasionmentioning
confidence: 99%